MA33351B1 - Formes stables du n-(2,6-diméthyl-4-morpholin-4-ylphényl)-3,3-diméthylbutyramide - Google Patents

Formes stables du n-(2,6-diméthyl-4-morpholin-4-ylphényl)-3,3-diméthylbutyramide

Info

Publication number
MA33351B1
MA33351B1 MA34435A MA34435A MA33351B1 MA 33351 B1 MA33351 B1 MA 33351B1 MA 34435 A MA34435 A MA 34435A MA 34435 A MA34435 A MA 34435A MA 33351 B1 MA33351 B1 MA 33351B1
Authority
MA
Morocco
Prior art keywords
dimethyl
morpholine
phenyl
stable form
dimethylbutyramide
Prior art date
Application number
MA34435A
Other languages
Arabic (ar)
English (en)
French (fr)
Inventor
Svend Treppendahl
Karin Liltorp
De Diego Heidi Lopez
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42237259&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA33351(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of MA33351B1 publication Critical patent/MA33351B1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MA34435A 2009-05-11 2010-05-11 Formes stables du n-(2,6-diméthyl-4-morpholin-4-ylphényl)-3,3-diméthylbutyramide MA33351B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200900597 2009-05-11
PCT/DK2010/050101 WO2010130260A2 (en) 2009-05-11 2010-05-11 Stable forms of n-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-3,3-dimethyl-butyramide

Publications (1)

Publication Number Publication Date
MA33351B1 true MA33351B1 (fr) 2012-06-01

Family

ID=42237259

Family Applications (1)

Application Number Title Priority Date Filing Date
MA34435A MA33351B1 (fr) 2009-05-11 2010-05-11 Formes stables du n-(2,6-diméthyl-4-morpholin-4-ylphényl)-3,3-diméthylbutyramide

Country Status (23)

Country Link
EP (1) EP2430008A2 (pt)
JP (1) JP2012526152A (pt)
KR (1) KR20120022934A (pt)
CN (1) CN102459208A (pt)
AR (1) AR076556A1 (pt)
AU (1) AU2010246724B2 (pt)
BR (1) BRPI1013930A2 (pt)
CA (1) CA2761383A1 (pt)
CL (1) CL2011002814A1 (pt)
CO (1) CO6460741A2 (pt)
CR (1) CR20110590A (pt)
DO (1) DOP2011000351A (pt)
EA (1) EA201171381A1 (pt)
GE (1) GEP20146006B (pt)
IL (1) IL216148A0 (pt)
MA (1) MA33351B1 (pt)
MX (1) MX2011011885A (pt)
NZ (1) NZ596738A (pt)
SG (1) SG175968A1 (pt)
TN (1) TN2011000557A1 (pt)
TW (1) TW201041857A (pt)
WO (1) WO2010130260A2 (pt)
ZA (1) ZA201108112B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119490430A (zh) 2019-08-02 2025-02-21 H.隆德贝克有限公司 用于在癫痫或癫痫发作中使用的作为Kv7钾通道开放剂的醇衍生物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI349666B (en) * 2004-03-12 2011-10-01 Lundbeck & Co As H Substituted morpholine and thiomorpholine derivatives
BRPI0716715B1 (pt) * 2006-08-23 2021-07-06 Xenon Pharmaceuticals, Inc Derivados de 4-(n-azacicloalquil) anilidas como moduladores de canal de potássio, seus usos, produto, composição, comprimido e cápsula
EP2185149A1 (en) * 2007-08-01 2010-05-19 H. Lundbeck A/S Use of kncq potassium channel openers for reducing symptoms of or treating disorders or conditions wherein the dopaminergic system is disrupted

Also Published As

Publication number Publication date
SG175968A1 (en) 2011-12-29
IL216148A0 (en) 2012-01-31
TW201041857A (en) 2010-12-01
BRPI1013930A2 (pt) 2019-09-24
CA2761383A1 (en) 2010-11-18
NZ596738A (en) 2013-04-26
CN102459208A (zh) 2012-05-16
EP2430008A2 (en) 2012-03-21
WO2010130260A2 (en) 2010-11-18
JP2012526152A (ja) 2012-10-25
MX2011011885A (es) 2011-12-06
TN2011000557A1 (en) 2013-05-24
CO6460741A2 (es) 2012-06-15
AR076556A1 (es) 2011-06-22
KR20120022934A (ko) 2012-03-12
CL2011002814A1 (es) 2012-04-13
WO2010130260A3 (en) 2011-06-16
GEP20146006B (en) 2014-01-10
AU2010246724A1 (en) 2011-12-08
EA201171381A1 (ru) 2012-05-30
CR20110590A (es) 2012-02-22
WO2010130260A9 (en) 2012-10-18
ZA201108112B (en) 2013-01-30
DOP2011000351A (es) 2012-01-31
AU2010246724B2 (en) 2013-03-21

Similar Documents

Publication Publication Date Title
EP2093223A4 (en) METHOD FOR PRODUCING AN ANTHRANILAMIDE COMPOUND
EP1991499A4 (en) METHOD FOR THE METAL-FREE SYNTHESIS OF EPITAXIAL SEMICONDUCTOR NANODRONS ON SI
EP2548862A4 (en) PROCESS FOR PREPARING AN AMID COMPOUND
EP2297033A4 (en) PROCESS FOR THE PREPARATION OF SILICON CARBIDE
EP2149545A4 (en) METHOD FOR PRODUCING A BENZALDEHYDE COMPOUND
EP2474560A4 (en) METHOD OF PREPARING AN 11 SUGAR SIALYLOLIGOSACCHARIDE PEPTIDE
EP2130583A4 (en) PROCESS FOR PREPARING A CARBONYL COMPOUND
EP2230333A4 (en) METHOD FOR BREEDING AN ALUMINUM NITRIDE CRYSTAL, PRODUCTION PROCESS FOR ALUMINUM NITRIDE CRYSTAL AND ALUMINUM NITRIDE CRYSTAL
MY146084A (en) Benzyl amines, a process for their production and their use as anti-inflammatory agents
EP2174927A4 (en) METHOD FOR PRODUCING A BETA-NITROSTYRENE COMPOUND
EP2442928A4 (en) HIGHLY EFFICIENT PLANT FOR STEEL MANUFACTURING
EP2213656A4 (en) METHOD FOR PRODUCING A CYANOHYDRIN COMPOUND AND METHOD FOR PRODUCING AN ALPHA HYDROXYESTER COMPOUND
EP2143718A4 (en) PROCESS FOR PREPARING A TETRAGLYCIDYLAMINE COMPOUND
EP2627620A4 (en) INTEGRATED METHOD FOR THE PRODUCTION OF FLUORIZED OLEFINS
EP2014634A4 (en) PROCESS FOR THE PREPARATION OF CYCLIC OLEFINES
EP2398926A4 (en) METHOD FOR PRODUCING HARDMETAL PRODUCTS
EP1944376A4 (en) PROCESS FOR PREPARING AN AMID COMPOUND
EP2256102A4 (en) PROCESS FOR PREPARING AN ALKOXYCARBONYL COMPOUND
EP1834949A4 (en) HIGHLY ALICYCLIC DIEPOXY COMPOUND AND PROCESS FOR THE PRODUCTION THEREOF
EP2415741A4 (en) METHOD FOR PRODUCING AN ALCOHOL COMPOUND
EA200870038A1 (ru) Способ получения аминов
EP2154123A4 (en) METHOD FOR PRODUCING A BENZALDEHYDE COMPOUND
EP1813596A4 (en) PROCESS FOR PREPARING ALPHA, ALPHA-DIFLUORAMINE
EP2077261A4 (en) METHOD FOR PRODUCING A SUCCINIMIDE COMPOUND
EP2514783A4 (en) METHOD FOR PRODUCING AN ORGANOPOLYSILOXAN COMPOUND